glp-1 retatrutide vs Semaglutide and Tirzepatide: GLP-3 Facts explained Retatrutide Weight Loss Results:Trial Data

This means we have limited data on the long-term effects of these drugs on humans

Compounded drugs are not FDA-approved products, and quality depends entirely on the pharmacy

Julia Edelman Executive Director of Womens Health Julia Schlam Edelman, MD is a gynecologist, author, and public speaker

Key Takeaways TRIUMPH-4 (obesity + knee osteoarthritis) reported 28.7% mean weight loss at 12 mg / 68 weeks TRANSCEND-T2D-1 reported HbA1c reductions up to 2.0%, read out March 19, 2026 A new safety signal dysesthesia (abnormal skin sensations) was observed at 20.9% incidence at the 12 mg dose NDA filing is expected Q4 2026